A survey of individuals with type 1 diabetes mellitus consuming a very low-carbohydrate diet indicated that many study participants were able to maintain glycemic control within national ideal glycemic target ranges.
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Artificial pancreas treatments are safe and effective for managing type 1 diabetes.
For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists significantly reduce mortality rates compared with dipeptidyl peptidase 4 inhibitors.
There is no statistically significant difference in weight loss at 5 years after laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass in morbidly obese patients.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Among women who are attempting to conceive naturally, diminished ovarian reserve is not associated with infertility.
The AAP Section for Endocrinology compiled the list of tests for height and puberty, which should prompt careful discussion between parents and physicians.
The researchers found no long-term increase in either all-cause or cause-specific mortality among women who received hormone therapy for up to 5.6 years or 7.2 years, depending on the type of therapy.
The gene-editing tool called CRISPR-Cas9 could have the potential to treat and prevent other genetic diseases.
The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
Thyroid disease may be a risk factor for manic relapse in patients with bipolar disorder.
Gestational weight gain greater than or less than guideline recommendations is associated with an increased risk of adverse outcomes.
The USPSTF recommends against screening for thyroid cancer in asymptomatic adults.
Patients taking linagliptin had decreased HbA1c as well as reactive oxygen species generation and plasma lipid peroxide levels.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
Current evidence is insufficient to weigh the balance of benefits and harms of screening.
When symptoms of thyroid disease are present, clinicians should check thyroid antibodies even if thyroid function is normal.
The eGMS system provides patient-specific insulin dosing.
Patients with acromegaly often exhibit breakthrough symptoms, despite stable treatment.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
Use of the Glucommander was linked to a shorter time to achieving blood glucose levels lower than 200 mg/dL.
Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.
Dose-response association, with 1.5-fold increase among those sleeping less than five hours
Although many older adults have metabolic syndrome, the rates are stable.
Patients with subclinical hypothyroidism who take statins have an increased risk of developing diabetes.
After adjustment for age and sex, standardized mortality ratios (SMRs) were higher in type 1 and type 2 diabetes for all outcomes.
Current insulin treatments and new agents to manage diabetes may be prohibitively expensive for patients without health insurance.
The glycated hemoglobin in the intensive control group was 6.9%, on average. For those on standard care, the glycated hemoglobin average was 8.4%.